Authors


Whitney Renee Smith, MD

Latest:

Are reusable catheters safe? Study provides an answer

"Patient perception is an important aspect of developing an effective treatment plan, and we should be able to arm patients with accurate data to help them make an informed decision," write Whitney Renee Smith, MD, and Gopal H. Badlani, MD.


Scott Donaldson, MD

Latest:

A patient’s dignity and daughter-and a race

"Like most doctors, the majority of my day is spent handholding, counseling, relieving anxiety, and otherwise dealing with problems that aren’t necessarily medical," writes urologist Scott Donaldson, MD.


Gina Columbus

Latest:

PD-1 inhibitor shows some antitumor activity in prostate cancer

With additional follow-up of approximately 10 months, monotherapy with the PD-1 inhibitor pembrolizumab (Keytruda) continued to show antitumor activity in men with metastatic castration-resistant prostate cancer. However, monotherapy alone is likely not a sufficient treatment in this patient population, according to Emmanuel Antonarakis, MBBCh, professor of oncology at Johns Hopkins University in Baltimore, Maryland.


Kevin Wright

Latest:

Analysis suggests survival improved when cytoreductive nephrectomy added to immunotherapy in mRCC

The primary objective of the study was to assess the benefit of cytoreductive nephrectomy relative to immunotherapy regimens utilizing checkpoint inhibitors.


James Anaissie, MD

Latest:

Addressing resident burnout starts with program’s culture

"I was overcome by the sinking notion that my career ambitions were regressing from thriving to surviving-a sentiment I know isn’t unique to my training. What may be unique, however, is how my program responded to increasingly evident signs of resident burnout," says James Anaissie, MD.


Jonathan Rubenstein, MD

Latest:

Medicare’s G2211 and thoughts on how to best use it in urology

"We felt that it was important to again address this topic because we have received numerous questions regarding the correct use of this code and we have had some experience using the code now that it is active and been able to observe some of the initial payment processing by the payer," write Jonathan Rubenstein, MD, and Mark Painter.


Thomas Chi, MD

Latest:

Robotic ureteroscopy: The future of stone management?

Advances in robotic URS will help target stones and reduce ionizing radiation.


Mitchell R. Humphreys, MD

Latest:

Robotic ureteroscopy: The future of stone management?

Advances in robotic URS will help target stones and reduce ionizing radiation.



Parth Patel, MD

Latest:

The case for transperineal prostate biopsy vs. the transrectal approach

Reduced infection rate may drive increased use of the transperineal approach.


Alex Belshoff, MD, PhD

Latest:

The case for transperineal prostate biopsy vs. the transrectal approach

Reduced infection rate may drive increased use of the transperineal approach.


Franklin Gaylis, MD

Latest:

An end to the decline in prostate cancer mortality

"The recently reported change in PCa death rates should prompt men to undergo genetic testing and have a discussion with their doctor regarding the benefits and potential harms of PSA-based screening based on their individualized risk of developing the disease," write Franklin Gaylis, MD, and A. Karim Kader, MD, PhD.


A. Karim Kader MD, PhD

Latest:

An end to the decline in prostate cancer mortality

"The recently reported change in PCa death rates should prompt men to undergo genetic testing and have a discussion with their doctor regarding the benefits and potential harms of PSA-based screening based on their individualized risk of developing the disease," write Franklin Gaylis, MD, and A. Karim Kader, MD, PhD.


Austin Lee

Latest:

Bicycle riding: Good or bad for men’s health?

Cycling has multiple benefits, and steps can be taken to prevent genitourinary injury.


Benjamin N. Breyer, MD, MAS

Latest:

Bicycle riding: Good or bad for men’s health?

Cycling has multiple benefits, and steps can be taken to prevent genitourinary injury.


Matthew D. Houlihan, DO

Latest:

Updated AUA guidelines on BPH: What urologists need to know

The updated guidelines focus on appropriate pre-procedure evaluation and novel surgical enhancements, according to Matthew D. Houlihan, DO, and Tobias S. Köhler, MD, MPH.


Tobias S. Köhler, MD, MPH

Latest:

Updated AUA guidelines on BPH: What urologists need to know

The updated guidelines focus on appropriate pre-procedure evaluation and novel surgical enhancements, according to Matthew D. Houlihan, DO, and Tobias S. Köhler, MD, MPH.


Adam J. Gadzinski, MD, MS

Latest:

Telemedicine in urology: A crash course during the COVID-19 pandemic

"Given that most urologic outpatient visits are non-urgent, almost all in-person visits should be eliminated out of appropriate concern for COVID-19," advise Drs. Gadzinski, Ellimoottil, Odisho, Watts, and Gore.


Anobel Y. Odisho, MD, MPH

Latest:

Telemedicine in urology: A crash course during the COVID-19 pandemic

"Given that most urologic outpatient visits are non-urgent, almost all in-person visits should be eliminated out of appropriate concern for COVID-19," advise Drs. Gadzinski, Ellimoottil, Odisho, Watts, and Gore.


Kara L. Watts, MD

Latest:

Telemedicine in urology: A crash course during the COVID-19 pandemic

"Given that most urologic outpatient visits are non-urgent, almost all in-person visits should be eliminated out of appropriate concern for COVID-19," advise Drs. Gadzinski, Ellimoottil, Odisho, Watts, and Gore.


John L. Gore, MD, MS

Latest:

Telemedicine in urology: A crash course during the COVID-19 pandemic

"Given that most urologic outpatient visits are non-urgent, almost all in-person visits should be eliminated out of appropriate concern for COVID-19," advise Drs. Gadzinski, Ellimoottil, Odisho, Watts, and Gore.


Amir H. Lebastchi, MD

Latest:

Expert Perspectives on the VIOLETTE Study and Future Directions in Prostate Cancer Research

Amir H. Lebastchi, MD, provides perspectives on the VIOLETTE study and underscores the importance of future head-to-head trials to gain a deeper understanding of various treatment approaches.


Luke O’Connor, PhD

Latest:

MRI/TRUS fusion-guided biopsy using UroNav

Pinto and colleagues provide an overview of MRI/TRUS fusion-guided transperineal biopsy utilizing the UroNav platform.


Peter A. Pinto, MD

Latest:

MRI/TRUS fusion-guided biopsy using UroNav

Pinto and colleagues provide an overview of MRI/TRUS fusion-guided transperineal biopsy utilizing the UroNav platform.


Arvin George, MD

Latest:

Freehand biopsy with PrecisionPoint system

George and colleagues demonstrate the use of the Michigan Urological Surgery Improvement Collaborative (MUSIC) template to perform a freehand transperineal prostate biopsy using the PrecisionPoint Transperineal Access System.


Andre L. Abreu, MD

Latest:

UroView: Gallium 68 PSMA–Targeted PET Imaging in Prostate Cancer: Staging and Outcomes

This article features insights from Phillip Kuo, MD, PhD, and Andre Abreu, MD, on gallium 68 PSMA-targeted PET imaging in prostate cancer.


Nathan Chertack, MD

Latest:

New developments may change treatment of OAB

"New treatments (pharmacological and device based) are currently in development to expand our OAB armamentarium," write Nathan Chertack, MD, and Gary Lemack, MD.


Gary Lemack, MD

Latest:

New developments may change treatment of OAB

"New treatments (pharmacological and device based) are currently in development to expand our OAB armamentarium," write Nathan Chertack, MD, and Gary Lemack, MD.


Alexander Small, MD

Latest:

Artificial intelligence is the new ghost author in urological research

“Although the future of AI within science is uncertain, disclosure of the use of AI is an excellent first step to balance academic integrity with disruptive innovation,” the authors write.


Rich Matulewicz, MD

Latest:

Acute-care urology during the pandemic: Lessons learned

"The goal of this narrative is to share details and lessons learned during our on-call urology coverage in the midst of the current pandemic so we can help others by informing planning," write Alexander Small, MD, and Rich Matulewicz, MD.

© 2024 MJH Life Sciences

All rights reserved.